Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced the presentation of new preclinical data for K…
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, a clinical-stage global biopharmaceutical company…
Horoscopes for October 27, 2025 Notable celebrities born on this day include Kelly Osbourne, Patrick Fugit, Peter Firth, and John Cleese.
EGAT Awards ANDRITZ Contract to Modernize Srinagarind Hydropower Plant The Electricity Generating Authority of Thailand (EGAT) has chosen …
Lululemon to Sell NFL Apparel in Fanatics Deal Lululemon has entered an arrangement with the NFL and Fanatics to develop a line of fan app…
Insurance: Protecting Against AI’s Dark Side Executives face AI-driven cyber threats. Insurers, reinsurers, and corporates are navigating …
Assessing the Success of Salt Lake City's 'No Kings' Protest Organizers of Salt Lake City's second "No Kings" protest have reflected on th…
Intersectional Disparities in Digital Health and Mental Health Service Use Among US Youth During the COVID-19 Pandemic A cross-sectional a…
Community Pharmacies and BioPharma: Collaborating for Comprehensive Patient Care The healthcare landscape is becoming increasingly complex…
CTD-ILD Burden on Older Patients and Women The incidence and prevalence of CTD-ILD significantly impact adults in the US, particularly old…
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology The global oncology market is rapidly shifting …